Anaconda Biomed
Anaconda Biomed develops funnel-shaped thrombectomy catheters that help neurointerventional physicians remove clots during treatment of large-vessel-occlusion stroke.
$56MSeries C
LeadLoading investors…
Activity from announced rounds
Anaconda Biomed develops funnel-shaped thrombectomy catheters that help neurointerventional physicians remove clots during treatment of large-vessel-occlusion stroke.
Develops an oral AKT inhibitor for hereditary hemorrhagic telangiectasia
Develops novel multifunctional antibodies for oncology and immunology & inflammation indications
Develops bispecific antibody CLD-423 for inflammatory bowel disease
Develops a Pulmonary Neuromodulation System for asthma treatment
Pitching Omega Funds? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room